Blog
RSS FeedPosted by Michael Wonder on 13 Jul 2019
Early benefit assessment reveals weaknesses in the development of new drugs
11 July 2019 - Analysis of 216 AMNOG assessments in the BMJ / Proposals for more targeted drug development ...
Posted by Michael Wonder on 08 Jul 2019
Report calls for European funding reform for gene therapies
8 July 2019 - New payment models, dedicated investment, and better health technology assessment are among a raft of changes ...
Posted by Michael Wonder on 08 Jul 2019
Pharma giant wants vaccination reform
9 July 2019 - Pharmaceutical giant GSK is calling for Australia to update its review of subsidised immunisation programs and ...
Posted by Michael Wonder on 07 Jul 2019
Fast-track drug approval, designed for emergencies, is now routine
5 July 2019 - Three-quarters of new drugs get an expedited regulatory review, thrusting families and doctors into a new world ...
Posted by Michael Wonder on 17 Jun 2019
Population adjustment methods for indirect comparisons: A review of NICE Technology Appraisals
13 June 2019 - Indirect comparisons via a common comparator (anchored comparisons) are commonly used in health technology assessment. However, ...
Posted by Michael Wonder on 31 May 2019
PBS process improvements webinar - information forum
31 May 2019 - The Department of Health will be hosting a webinar on 14 June 2019 to provide industry, ...
Posted by Michael Wonder on 14 Apr 2019
Use of multiple sclerosis medicine Lemtrada restricted while EMA review is ongoing
12 April 2019 - EMA has started a review of the multiple sclerosis medicine Lemtrada (alemtuzumab) following new reports of ...
Posted by Michael Wonder on 13 Apr 2019
Missing from the PBM hearings: value based drug reimbursement
11 April 2019 - This week, committees in both the Senate and House of Representatives used their power to shine ...
Posted by Michael Wonder on 11 Apr 2019
Select committee inquiry into PHARMAC would be too slow - Labour
12 April 2019 - The Government says a select committee inquiry into PHARMAC's drug-buying processes would take longer than current ...
Posted by Michael Wonder on 11 Apr 2019
Peters accuses Bennett of using people's illnesses to gain 'political points' in exchange about PHARMAC funding
11 April 2019 - Winston Peters accused Paula Bennett of using people's illnesses to gain "political points" during an exchange ...
Posted by Michael Wonder on 11 Apr 2019
Labour MP rejects claims she said Health Minister nixed PHARMAC inquiry
11 April 2019 - Labour MP health select committee chair Louisa Wall is rejecting claims she told the husband of a ...
Posted by Michael Wonder on 09 Apr 2019
Official inquiry into PHARMAC necessary
10 April 2019 - Today National MP Michael Woodhouse is set to table a motion calling on the Health Select ...
Posted by Michael Wonder on 07 Apr 2019
Health insurers welcome Coalition review on natural therapies
8 April 2019 - Health insurers have welcomed a Coalition pledge to reconsider a ban on cover for natural therapies ...
Posted by Michael Wonder on 20 Mar 2019
FDA reform: it’s time to act, but not as an independent agency
19 March 2019 - In a rare exercise in bipartisan leadership, former FDA commissioners of both political parties called, in ...
Posted by Michael Wonder on 13 Mar 2019
Women with advanced breast cancer ask health select committee for PHARMAC review
13 March 2019 - Ten women today spoke one after the other, telling a committee of MPs how desperately they ...